Picture of Carl Zeiss Meditec AG logo

AFX — Carl Zeiss Meditec AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Carl Zeiss Meditec Expects 2023/24 EBIT To be Around Prior Year's Level

Feb 9 (Reuters) - CARL ZEISS MEDITEC AG  AFXG.DE :
    * ACHIEVES SLIGHT REVENUE GROWTH IN FIRST QUARTER OF 2023/24
    * Q1 ORDER BACKLOG NORMALIZED TO AROUND EUR 315M
    * COMPANY GENERALLY EXPECTS TO SEE FURTHER MARKET GROWTH IN
COMING
YEAR 23/4
    * EBIT FOR FISCAL YEAR 2023/24 AS A WHOLE IS EXPECTED TO BE
AROUND
PRIOR YEAR'S LEVEL
    * REVENUE IS EXPECTED TO GROW AT LEAST IN LINE WITH MARKET
GROWTH
FY 23/4
    * A GRADUAL RECOVERY OF EBIT MARGIN IS EXPECTED IN FURTHER
COURSE
OF YEAR
    * EBIT MARGIN IN FIRST THREE MONTHS OF FISCAL YEAR 2023/24
WAS
9.2% (PRIOR YEAR: 12.8%)

Source text for Eikon:  ID:nEQ2dcBNSa 
Further company coverage:  AFXG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Carl Zeiss Meditec AG

See all news